Praxis Precision Medicines Inc. (PRAX) PT Raised to $575 at Goldman Sachs
Tweet
Share
E-mailGet Alerts PRAX Hot Sheet
Price: $300.65 +0.60%
Rating Summary:
18 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 10 | New: 48
Rating Summary:
18 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 10 | New: 48
Join SI Premium – FREE
Goldman Sachs analyst Kevin Strang raised the price target on Praxis Precision Medicines Inc. (NASDAQ: PRAX) to $575.00 (from $470.00) while maintaining a Buy rating.
You May Also Be Interested In
- Chord Energy Corp (CHRD) PT Lowered to $184 at UBS on Model Updates Following Non-Core Marcellus Sale
- CPI Card Group (PMTS) PT Raised to $30 at Lake Street
- Suntec REIT (SUN:SP) PT Lowered to SGD1.40 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
